YIH
EDIT icon

Y-Intercept (HK)’s Editas Medicine EDIT Stock Holding History

Y-Intercept (HK)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,662
Closed -$46.6K – 1294
2024
Q3 		$46.6K Buy
+13,662
New +$59.5K ﹤0.01% 1227
2024
Q1 		– Sell
-18,214
Closed -$185K – 1460
2023
Q4 		$185K Buy
+18,214
New +$160K 0.02% 1018
2023
Q3 		– Sell
-27,340
Closed -$225K – 1176
2023
Q2 		$225K Buy
+27,340
New +$238K 0.02% 888
2021
Q3 		– Sell
-4,877
Closed -$276K – 712
2021
Q2 		$276K Sell
4,877
-1,579
-24% -$58.3K 0.07% 432
2021
Q1 		$261K Buy
+6,456
New +$368K 0.07% 466

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Y-Intercept (HK)'s EDIT Position: Q4 2024 in Review

Y-Intercept (HK) sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 13,662 shares — an estimated $46.6K sold.

Y-Intercept (HK) first reported a position in EDIT in Q1 2021 and held it in 5 quarters. The position peaked at $276K in Q2 2021. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Y-Intercept (HK) reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 13,662 Editas Medicine shares in Q4 2024, an estimated $46.6K.
  • Y-Intercept (HK) first reported a position in Editas Medicine in Q1 2021 and held it in 5 quarters.
  • Y-Intercept (HK)'s Editas Medicine position peaked at $276K in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Y-Intercept (HK)'s 13F filing for Q4 2024, filed 4 Feb 2025.